C07K 14/524
Thrombopoietin, i.e. c-mpl ligand
Official title: {Thrombopoietin, i.e. C-MPL ligand}
C07K14/524 (Thrombopoietin, i.e. c-mpl ligand) appears on 93 US grants and 111 published applications in this corpus.
Search patents in C07K- Granted patents
- 93
- Published applications
- 111
- Assignees
- 56
- Inventors
- 237
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 1 |
| 2003 | 3 | 9 |
| 2004 | 3 | 13 |
| 2005 | 3 | 7 |
| 2006 | 4 | 4 |
| 2007 | 4 | 6 |
| 2008 | 3 | 2 |
| 2009 | 6 | 7 |
| 2010 | 1 | 5 |
| 2011 | 5 | 5 |
| 2012 | 8 | 6 |
| 2013 | 7 | 7 |
| 2014 | 4 | 2 |
| 2015 | 3 | 4 |
| 2016 | 2 | 4 |
| 2017 | 3 | 2 |
| 2018 | 2 | 3 |
| 2019 | 5 | 4 |
| 2020 | 3 | 2 |
| 2021 | 3 | 4 |
| 2022 | 0 | 4 |
| 2023 | 2 | 1 |
| 2024 | 1 | 5 |
| 2025 | 2 | 2 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Methods for the purification of refolded Fc-peptide fusion protein3 Feb 2026US 12,540,160 B2Richter Gedeon Nyrt.
- Genetically modified mice and engraftment2 Sep 2025US 12,402,611 B2Regeneron Pharmaceuticals, Inc.
- Process for lyophilized pharmaceutical formulations of a therapeutic protein18 Mar 2025US 12,251,474 B2Amgen Inc.
- Genetically modified non-human animals and methods of use thereof29 Oct 2024US 12,127,537 B2Regeneron Pharmaceuticals, Inc.
- Genetically Modified Mice and Engraftment5 Mar 2026US 2026/0060222 A1Institute for Research in Biomedicine (IRB)
- Flt3 ligand bi-functional molecules for thrombopenia and acute radiation syndrome26 Feb 2026US 2026/0055210 A1Albert Einstein College of Medicine
- Genetically Modified Non-Human Animals And Methods Of Use Thereof6 Mar 2025US 2025/0072405 A1Institute for Research in Biomedicine (IRB)
- Method for the manufacture of biopharmaceuticals9 Jan 2025US 2025/0011382 A1Richter Gedeon Nyrt.
- Tpo mimetic fusion proteins and methods of use28 Nov 2024US 2024/0391977 A1Sichuan Clover Biopharmaceuticals, Inc.
Most cited
By later US patents
- Modified peptides as therapeutic agents359US 6,660,843 B1Amgen Inc. · 2003
- Peptides and compounds that bind to a receptor112US 5,869,451 AGlaxo Group Limited · 1999
- Method for treating mammals with monopegylated proteins that stimulates megakaryocyte growth and differentiation82US 5,766,581 AAmgen Inc. · 1998
- Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation80US 5,795,569 AAmgen Inc. · 1998
- Peptides and compounds that bind to a receptor78US 6,251,864 B1Glaxo Group Limited · 2001